Quality over quantity: A qualitative, targeted bottom-up proteomics approach to genotyping apolipoprotein L1
Tài liệu tham khảo
Chen, 2011, Simultaneous phenotyping and quantification of -1-antitrypsin by liquid chromatography-tandem mass spectrometry, Clin. Chem., 57, 1161, 10.1373/clinchem.2011.163006
Lim, 2002, Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis, Anal. Chem., 74, 741, 10.1021/ac010780+
Wild, 2001, Rapid identification of hemoglobin variants by electrospray ionization mass spectrometry, Blood Cells, Mol. Dis., 27, 691, 10.1006/bcmd.2001.0430
Nishimura, 2014, Human apolipoprotein E resequencing by proteomic analysis and its application to serotyping, PloS one, 9, 7, 10.1371/journal.pone.0085356
He, 2019, Diagnosis of hemoglobinopathy and β-thalassemia by 21 tesla fourier transform ion cyclotron resonance mass spectrometry and tandem mass spectrometry of hemoglobin from blood, Clin. Chem., 65, 986, 10.1373/clinchem.2018.295766
Maus, 2019, Center of mass calculation in combination with MS/MS allows robust identification of single amino acid polymorphisms in clinical measurements of insulin-like growth factor-1, J. Proteome Res., 19, 186, 10.1021/acs.jproteome.9b00494
Limou, 2014, APOL1 kidney risk alleles: population genetics and disease associations, Adv. Chronic Kidney Dis., 21, 426, 10.1053/j.ackd.2014.06.005
Bruggeman, 2014, Plasma apolipoprotein L1 levels do not correlate with CKD, J. Am. Soc. Nephrol., 25, 634, 10.1681/ASN.2013070700
Genovese, 2010, Association of trypanolytic ApoL1 African Americans, 67
Kopp, 2011, APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy, J. Am. Soc. Nephrol., 22, 2129, 10.1681/ASN.2011040388
Friedman, 2011, Population-based risk assessment of APOL1 on renal disease, J. Am. Soc. Nephrol., 22, 2098, 10.1681/ASN.2011050519
Freedman, 2014, End-stage renal disease in African Americans with lupus nephritis is associated With APOL1, Arthritis Rheumatol., 66, 390, 10.1002/art.38220
Reeves-Daniel, 2011, The APOL1 gene and allograft survival after kidney transplantation, Am. J. Transplant., 11, 1025, 10.1111/j.1600-6143.2011.03513.x
Freedman, 2015, Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure, Am. J. Transplant., 15, 1615, 10.1111/ajt.13223
Freedman, 2016, APOL1 genotype and kidney transplantation outcomes from deceased African American donors, Transplantation, 100, 194, 10.1097/TP.0000000000000969
Organ Procurement and Transplantation Network, A Guide to Calculating and Interpreting the Kidney Donor Profle Index (KDPI), (2019) 1–11. https://optn.transplant.hrsa.gov/media/1512/guide_to_calculating_interpreting_kdpi.pdf.
Akkina, 2012, Development of organ-specific donor risk indices, Liver Transplant., 18, 395, 10.1002/lt.23398
Kopp, 2020, Genetic testing for APOL1 genetic variants in clinical practice finally starting to arrive, Clin. J. Am. Soc. Nephrol., 15, 126, 10.2215/CJN.01810219
Zhou, 2013, Rapid detection and quantification of apolipoprotein L1 genetic variants and total levels in plasma by ultra-performance liquid chromatography/tandem mass spectrometry, Rapid Commun. Mass Spectrom., 27, 2639, 10.1002/rcm.6734
Zhang, 2016, Analytical validation of a personalized medicine APOL1 genotyping assay for nondiabetic chronic kidney disease risk assessment, J. Mol. Diagnostics, 18, 260, 10.1016/j.jmoldx.2015.11.003
Madhavan, 2011, APOL1 localization in normal kidney and nondiabetic kidney disease, J. Am. Soc. Nephrol., 22, 2119, 10.1681/ASN.2011010069
MacLean, 2010, Skyline: an open source document editor for creating and analyzing targeted proteomics experiments, Bioinformatics, 26, 966, 10.1093/bioinformatics/btq054
MacLean, 2010, Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry, Anal. Chem., 82, 10116, 10.1021/ac102179j
Kozlitina, 2016, Plasma levels of risk-variant APOL1 do not associate with renal disease in a population-based cohort, J. Am. Soc. Nephrol., 27, 3204, 10.1681/ASN.2015101121
